Core Viewpoint - MindBio Therapeutics Corp. has launched an extended showcase of its AI-powered voice technology for drug and alcohol intoxication detection in the USA, coinciding with its listing on the OTCQB Market [1]. Group 1: Technology Development - The company has developed a voice-activated AI technology that predicts intoxication, utilizing proprietary algorithms based on extensive data from drug and alcohol clinical trials, achieving remarkable accuracy in detecting alcohol and hallucinogenic drugs [2]. - MindBio's technology is designed to expand its detection capabilities to include other prohibited drugs that are challenging to identify at scale, requiring only a simple voice analysis [3]. - The company has created a world-first AI model that uses over 50 million data points to predict alcohol intoxication accurately through voice analysis, including estimating blood alcohol concentration levels with the launch of the Booze AI app in 2025 [5]. Group 2: Market Applications - The voice analytics solution is positioned as a transformative tool for intoxication detection in regulated workplace environments, such as mining, aviation, and construction, where traditional testing methods are costly and time-consuming [4]. - MindBio is developing an enterprise version of its technology for various applications, including workplace environments, call centers, mental health, and law enforcement, with plans to announce further developments and potential commercial applications soon [6]. Group 3: Company Overview - MindBio Therapeutics Corp. is a biotechnology company based in Vancouver, British Columbia, specializing in drug and alcohol research and health prediction technologies using AI and machine learning [8].

Company Overview - MindBio Therapeutics Corp. is a biotechnology company based in Vancouver, British Columbia, specializing in clinical health research and the development of AI-powered health prediction technologies [6] - The company has created a world-first AI prediction tool for drug and alcohol intoxication detection using voice analytics [6] Recent Developments - MindBio has listed its common shares for trading on the OTCQB Market, expanding its reach to US investors and a larger audience interested in AI and predictive health technologies [5][2] - The company is launching an extended roadshow in the USA to promote its voice and AI-powered drug and alcohol intoxication technology [2] Technology and Innovation - MindBio has developed an AI model that utilizes over 50 million data points to predict alcohol intoxication with high accuracy based solely on human voice [3] - The company successfully launched the Booze AI app in 2025, which estimates actual blood alcohol concentration levels [3] - MindBio is also working on an enterprise version and new platform-level technology for health prediction, aiming to expand its applications in workplace environments, call centers, mental health, and law enforcement [4] Future Prospects - The company plans to make announcements regarding the progress of its new technology, products, markets, and potential commercial applications in the near future [4]